MIRA Pharmaceuticals logo
MIRA Pharmaceuticals
MIRA | NASDAQ
Chart Builder DCF Calculator
$0.63
-$0.03 (-4.52%)
At close: Nov 16, 2026, 4:00 PM ET
$0.63
$0.00 (+0.16%)
After-hours: Nov 16, 2026, 4:10 PM ET

MIRA Pharmaceuticals Company Profile

Company profile explained

Company Profile

MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.

Key Executives

Name Position
Erez Aminov Chief Executive Officer & Chairman
Andriy Mushak Chief Financial Officer
Itzchak Angel Chief Scientific Advisor

Latest SEC Filings

Date Type Title
Oct 28, 2026 8-K Current Report
Oct 22, 2026 8-K Current Report
Sep 17, 2026 8-K Current Report
Sep 16, 2026 8-K Current Report
Sep 01, 2026 8-K Current Report
Aug 12, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 31, 2026 8-K Current Report
Jul 28, 2026 DEF 14A Filing
Jul 10, 2026 8-K Current Report
View All SEC Filings ➞
MIRA Pharmaceuticals
MIRA Pharmaceuticals logo
Country United States
IPO Date Aug 3, 2023
Industry Drug Manufacturers - General
Sector Healthcare
Employees 2
CEO Erez Aminov

Contact Details

1200 Brickell Avenue Miami, Florida 33131 United States

Stock Details

Ticker Symbol MIRA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001904286
CUSIP Number 60458C104
ISIN Number US60458C1045
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.